Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach.
Study Goal
The researchers aimed to review the preventive role of vitamin D and hip protectors on hip fractures in older patients with sarcopenia.
Results Summary
The study suggests that vitamin D may protect against hip fractures through skeletal (increased mineralization) and extra-skeletal (reduced fall risk) mechanisms, though clinical trials are needed to confirm efficacy.
Population
Older patients with sarcopenia and osteosarcopenia.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D | decrease | hip fractures | older patients with sarcopenia | - | protective actions against | #1 |
vitamin D | increase | mineralization | - | - | increased | #2 |
vitamin D | decrease | falls | - | - | reduced risk of | #3 |
hip protectors | decrease | falls | - | - | attenuating the effects of | #4 |
concomitant use of vitamin D and hip protectors | decrease | hip fractures | older patients with sarcopenia | - | may represent an effective strategy in the prevention of | #5 |
Osteosarcopenia is an emerging clinical condition highly prevalent in the older people. Affected subjects due to their intrinsic skeletal fragility and propensity to falls are at elevated risk of hip fractures which can increase morbidity and mortality. Strategies for attenuating the impact of predisposing factors on hip fractures are not yet well defined and should derive from multidisciplinary care and collaborations. Our aim was to narratively review available data on the preventive role of vitamin D and hip protectors on hip fractures in older patients with sarcopenia. Older subjects are at high risk of vitamin D deficiency and of falls due to several concomitant factors besides osteosarcopenia. Vitamin D protective actions against hip fractures may be mediated by both skeletal (increased mineralization) and extra-skeletal (reduced risk of falls) actions. Hip protectors may act downstream attenuating the effects of falls although their use is still not yet enough widespread due to the suboptimal compliance obtained by traditional hard devices. Concomitant use of vitamin D and hip protectors may represent an effective strategy in the prevention of hip fractures which need to be tested in ad hoc designed clinical trials.